Baird Financial Group’s NuVasive, Inc. NUVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-6,915
Closed -$340K 1871
2022
Q2
$340K Buy
6,915
+38
+0.6% +$2.04K ﹤0.01% 1499
2022
Q1
$390K Sell
6,877
-232
-3% -$12.3K ﹤0.01% 1515
2021
Q4
$373K Hold
7,109
﹤0.01% 1589
2021
Q3
$425K Buy
+7,109
New +$438K ﹤0.01% 1532
2018
Q1
Sell
-3,500
Closed -$205K 1322
2017
Q4
$205K Buy
+3,500
New +$198K ﹤0.01% 1210
2017
Q3
Sell
-3,518
Closed -$271K 1270
2017
Q2
$271K Buy
3,518
+18
+0.5% +$1.34K ﹤0.01% 1110
2017
Q1
$261K Hold
3,500
﹤0.01% 1108
2016
Q4
$236K Hold
3,500
﹤0.01% 1105
2016
Q3
$233K Hold
3,500
﹤0.01% 1112
2016
Q2
$209K Buy
+3,500
New +$189K ﹤0.01% 1134

Other funds holding NUVA

Baird Financial Group's NUVA Position: Q3 2022 in Review

Baird Financial Group sold out of NuVasive, Inc. (NUVA) in Q3 2022, closing a stake of 6,915 shares — an estimated $340K sold.

Baird Financial Group first reported a position in NUVA in Q2 2016 and held it in 10 quarters. The position peaked at $425K in Q3 2021. 232 funds tracked by Wall St. Rank hold NUVA as of Q3 2022.

  • Baird Financial Group reported no remaining NuVasive, Inc. position as of Q3 2022 after selling out during the quarter.
  • Baird Financial Group sold 6,915 NuVasive, Inc. shares in Q3 2022, an estimated $340K.
  • Baird Financial Group first reported a position in NuVasive, Inc. in Q2 2016 and held it in 10 quarters.
  • Baird Financial Group's NuVasive, Inc. position peaked at $425K in Q3 2021.
  • 232 funds tracked by Wall St. Rank held NuVasive, Inc. as of Q3 2022.

Based on Baird Financial Group's 13F filing for Q3 2022, filed 15 Nov 2022.